Schedule 13G ownership disclosure

ZIOPHARM ONCOLOGY INC

Security class unavailable · CUSIP: 98973P101

Event date: 2020-11-05

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
9,627,879
Percent of class
4.5000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-20-126942
Form type
SC 13G/A
Filer
WHITE ROCK CAPITAL MANAGEMENT LP
CIK
CIK 1051272
Filed
Nov 18, 2020
Reporting period
Nov 05, 2020
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub